ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 30 filers reported holding ZOSANO PHARMA CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $24,000 | -96.1% | 77,663 | -97.1% | 0.02% | -94.8% |
Q1 2022 | $612,000 | -52.1% | 2,718,226 | 0.0% | 0.33% | -26.8% |
Q4 2021 | $1,278,000 | -34.7% | 2,718,226 | 0.0% | 0.45% | +15.6% |
Q3 2021 | $1,956,000 | -24.3% | 2,718,226 | 0.0% | 0.39% | -5.8% |
Q2 2021 | $2,583,000 | -23.4% | 2,718,226 | 0.0% | 0.41% | -31.8% |
Q1 2021 | $3,371,000 | +135.2% | 2,718,226 | 0.0% | 0.61% | +146.7% |
Q4 2020 | $1,433,000 | -67.5% | 2,718,226 | 0.0% | 0.25% | -82.5% |
Q3 2020 | $4,404,000 | +89.2% | 2,718,226 | 0.0% | 1.41% | +58.4% |
Q2 2020 | $2,328,000 | +52.4% | 2,718,226 | 0.0% | 0.89% | +33.3% |
Q1 2020 | $1,528,000 | -63.0% | 2,718,226 | 0.0% | 0.67% | -57.9% |
Q4 2019 | $4,132,000 | +30.6% | 2,718,226 | +34.0% | 1.58% | -4.1% |
Q3 2019 | $3,165,000 | -52.3% | 2,028,571 | 0.0% | 1.65% | -41.8% |
Q2 2019 | $6,633,000 | -13.1% | 2,028,571 | +26.8% | 2.83% | -51.3% |
Q1 2019 | $7,632,000 | +125.0% | 1,600,000 | 0.0% | 5.81% | +62.7% |
Q4 2018 | $3,392,000 | – | 1,600,000 | – | 3.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,600,000 | $7,632,000 | 5.81% |
Telemetry Investments, L.L.C. | 242,826 | $1,158,000 | 0.59% |
MYDA Advisors LLC | 72,000 | $343,000 | 0.17% |
Highlander Capital Management, LLC | 10,000 | $48,000 | 0.03% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $4,770,000 | 0.01% |
Hartford Financial Management Inc. | 2,000 | $10,000 | 0.00% |
GABELLI FUNDS LLC | 21,297 | $102,000 | 0.00% |
IFP Advisors, Inc | 1,248 | $6,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 81,829 | $390,000 | 0.00% |
DEUTSCHE BANK AG\ | 100 | $0 | 0.00% |